Under the deal, Hims & Hers will offer patients access to FDA-approved versions of Ozempic and Wegovy at the same self-pay prices available through other telehealth platforms
The construction projects, which have already begun, will be finalised gradually from the end of 2027 through 202
The company said the move applies to all doses and reflects its commitment to making its medicines more affordable for patients
Wegovy is now offered in six weekly doses in the EU: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg, and the newly approved 7.2 mg dose
Operating profit fell 1% in Danish kroner to DKK 127.7 billion but rose 6% at constant exchange rates
The approval introduces a needle-free alternative to injectable GLP-1 therapies
Wegovy pill showed a mean weight loss of 16.6% in the OASIS 4 trial
Wegovy achieved significant weight loss with one in three study participants losing 20% or more body weight
The survey revealed that the proportion of individuals experiencing constant thoughts about food throughout the day declined by 46 percent after starting Wegovy
Subscribe To Our Newsletter & Stay Updated
